Preoperative risk evaluation: Where is the limit for recipients of a pancreatic graft?

Current Opinion in Organ Transplantation

Volumn 18, Issue 1, 2013, Pages 97-101

  Eller, Kathrin ^a   Kniepeiss, Daniela ^a   Rosenkranz, Alexander R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

pancreas transplantation; preoperative risk evaluation; simultaneous kidney pancreas transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGE; ANGIOCARDIOGRAPHY; CANCER SCREENING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETIC PATIENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GRAFT FAILURE; GRAFT RECIPIENT; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LUNG INFECTION; MAGNETIC RESONANCE ANGIOGRAPHY; OBESITY; PANCREAS TRANSPLANTATION; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; OBESITY; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK ASSESSMENT;

EID: 84872902005     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835c9666     Document Type: Review

References (43)

1. Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339:69-75.
2. Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care 2006; 29:935.
3. Gruessner AC, Sutherland DE, Gruessner RW. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 2010; 15:93-101.
4. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet 2009; 373:1808-1817.
5. Giannarelli R, Coppelli A, Sartini MS, et al. Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia 2006; 49:2977-2982.
6. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730.
7. Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4:2018-2026.
8. Becker BN, Rush SH, Dykstra DM, et al. Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med 2006; 166:44-48.
9. Wiseman AC. Simultaneous pancreas kidney transplantation: a critical appraisal of the risks and benefits compared with other treatment alternatives. Adv Chronic Kidney Dis 2009; 16:278-287.
10. Douzdjian V, Escobar F, Kupin WL, et al. Cost-utility analysis of living-donor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-kidney transplantation. Clin Transplant 1999; 13:51-58.
11. Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.1. Cardiovascular risks. Cardiovascular disease after renal transplantation. Nephrol Dial Transplant 2002; 17 (Suppl 4):24-25.
12. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
13. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999, 100:1132-1133.
14. Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 2001; 38:S26-29.
15. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44:617-621.
16. Patel RK, Mark PB, Johnston N, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant 2008; 8:1673-1683.
17. Kasiske BL, Israni AK, Snyder JJ, et al. Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis 2011; 57:908-916.
18. Zaman F, Abreo KD, Levine S, et al. Pancreatic transplantation: evaluation and management. J Intensive Care Med 2004; 19:127-139.
19. De Lima JJ, Sabbaga E, Vieira ML, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42:263-268.
20. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005; 80:815-820.
21. Sharples EJ, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis 2004; 43:313-319.
22. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003; 26:1258-1264.
23. Schenker P, Vonend O, Kruger B, et al. Long-term results of pancreas transplantation in patients older than 50 years. Transpl Int 2011; 24:136-142.
24. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2005; 19:433-455.
25. Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231:269-275.
26. Ablorsu E, Ghazanfar A, Mehra S, et al. Outcome of pancreas transplantation in recipients older than 50 years: a single-centre experience. Transplantation 2008; 86:1511-1514.
27. Sinclair AJ, Alexander CM, Davies MJ, et al. Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes. BMC Endocr Disord 2012; 12:1.
28. Salvalaggio PR, Schnitzler MA, Abbott KC, et al. Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant 2007; 7:1561-1571.
29. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19:433-455.
30. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1, 000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
31. Stratta RJ. Mortality after vascularized pancreas transplantation. Surgery 1998; 124:823-830.
32. Afaneh C, Rich BS, Aull MJ, et al. Pancreas transplantation: does age increase morbidity? J Transplant 2011; 2011:596801.
33. Friedman AN, Miskulin DC, Rosenberg IH, Levey AS. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003; 41:480-487.
34. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84:981-987.
35. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006; 6:357-363.
36. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact ofbody mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73:70-74.
37. Bumgardner GL, Henry ML, Elkhammas E, et al. Obesity as a risk factor after combined pancreas/kidney transplantation. Transplantation 1995; 60:1426-1430.
38. Hanish SI, Petersen RP, Collins BH, et al. Obesity predicts increased overall complications following pancreas transplantation. Transplant Proc 2005; 37:3564-3566.
39. Humar A, Ramcharan T, Kandaswamy R, et al. Technical failures after pancreas transplants: why grafts fail and the risk factors-a multivariate analysis. Transplantation 2004; 78:1188-1192.
40. Rogers J, Chavin KD, Baliga PK, et al. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg 2003; 7:1096-1101.
41. Sampaio MS, Reddy PN, Kuo HT, et al. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation 2010; 89:1117-1125.
42. Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290:2817-2823.
43. Glanton CW, Kao TC, Cruess D, et al. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003; 63:647-653.